Globus Medical (GMED)
(Real Time Quote from BATS)
$69.67 USD
-0.73 (-1.04%)
Updated Oct 2, 2024 10:54 AM ET
3-Hold of 5 3
C Value C Growth C Momentum C VGM
Cash flow Statements
Fiscal Year End for Globus Medical, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 122.87 | 190.17 | 149.19 | 102.29 | 155.21 |
Depreciation/Amortization & Depletion | 225.36 | 73.64 | 72.65 | 63.46 | 51.65 |
Net Change from Assets/Liabilities | -116.60 | -105.26 | -17.25 | -37.59 | -73.44 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 11.87 | 19.92 | 71.69 | 70.64 | 38.56 |
Net Cash From Operating Activities | 243.50 | 178.47 | 276.27 | 198.79 | 171.98 |
Property & Equipment | -78.27 | -74.05 | -56.90 | -63.66 | -70.75 |
Acquisition/ Disposition of Subsidiaries | -296.03 | -31.44 | -34.49 | -33.48 | -23.80 |
Investments | 677.27 | -4.88 | -284.55 | -20.18 | -45.73 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 302.97 | -110.36 | -375.94 | -117.32 | -140.28 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -213.17 | -102.78 | 63.50 | -32.35 | 31.04 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -18.66 | -7.19 | -9.35 | -6.32 | -6.60 |
Net Cash from Financing Activities | -231.82 | -109.96 | 54.15 | -38.66 | 24.44 |
Effect of Exchange Rate Changes | 2.18 | -0.75 | -0.81 | 0.87 | -0.16 |
Net Change In Cash & Equivalents | 316.83 | -42.60 | -46.33 | 43.67 | 55.98 |
Cash at Beginning of Period | 150.47 | 193.07 | 239.40 | 195.72 | 139.75 |
Cash at End of Period | 467.29 | 150.47 | 193.07 | 239.40 | 195.72 |
Diluted Net EPS | 1.07 | 1.85 | 1.44 | 1.01 | 1.52 |
Fiscal Year End for Globus Medical, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 24.64 | -7.12 | 122.87 | 107.84 | 106.84 |
Depreciation/Amortization & Depletion | 239.49 | 115.61 | 225.36 | 93.37 | 36.97 |
Net Change from Assets/Liabilities | -159.68 | -42.72 | -116.60 | -71.20 | -69.61 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 2.19 | -13.39 | 11.87 | 8.82 | 14.14 |
Net Cash From Operating Activities | 106.65 | 52.39 | 243.50 | 138.83 | 88.34 |
Property & Equipment | -56.37 | -28.57 | -78.27 | -55.39 | -33.86 |
Acquisition/ Disposition of Subsidiaries | -17.54 | -12.65 | -296.03 | -296.03 | -2.66 |
Investments | 16.94 | -5.37 | 677.27 | 333.77 | 99.74 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -56.96 | -46.58 | 302.97 | -17.65 | 63.21 |
Uses of Funds
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -67.14 | -79.90 | -213.17 | 11.36 | 8.06 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -39.88 | -35.82 | -18.66 | -5.91 | -4.03 |
Net Cash from Financing Activities | -107.01 | -115.72 | -231.82 | 5.45 | 4.02 |
Effect of Exchange Rate Changes | 0.46 | -3.31 | 2.18 | 2.53 | 0.41 |
Net Change In Cash & Equivalents | -56.87 | -113.23 | 316.83 | 129.15 | 155.99 |
Cash at Beginning of Period | 467.29 | 467.29 | 150.47 | 150.47 | 150.47 |
Cash at End of Period | 410.42 | 354.06 | 467.29 | 279.62 | 306.45 |
Diluted Net EPS | 0.23 | -0.05 | 0.01 | 0.01 | 0.57 |